Continuing education credits may be received for many of our webinars, when they are viewed live. Ambry Genetics is in the industry of: Medical Testing & Clinical Laboratories, Healthcare. © 2020 Ambry Genetics. To use all the functions on Chemie.DE please activate JavaScript. Ambry Genetics’s official website is Read what you need to know about our industry portal Operator of a genetics diagnostics company designed to provide a comprehensive suite of genetic testing applications for inherited and non-inherited diseases. With an accout for you can always see everything at a glance – and you can configure your own website and individual newsletter. How many employees are working in Ambry Genetics? What is Ambry Genetics’s official website? Whole Exome Sequencing Market to Reflect Significant Growth During 2020–2027 : BGI, Ambry Genetics, Eurofins Genomics, Etc News and bulletins about Ambry Genetics for biotechnology, life sciences, pharmacy, healthcare, diagnostics, bioinformatics, updated daily and relevant to the sector, can be found on this page. Ambry Genetics News & Media. Ambry Genetics supports ongoing clinician education and data sharing, to help promote scientific discoveries that help improve patient management and care. Your browser does not support JavaScript. To use all functions of this page, please activate cookies in your browser. Vice President, Bioinformatics and Computatio... Ambry Genetics’s headquarters are in 1 Enterprise, Aliso Viejo, California, 92656, United States, Ambry Genetics’s phone number is (949) 900-5500. ALISO VIEJO, Calif., Feb. 25, 2020 /PRNewswire/ -- Ambry Genetics (Ambry), a leading clinical genetic testing lab, announced the publication of a study in Nature Partner Journal Precision Oncology finding that RNA genetic testing, conducted at the same time as DNA testing, identifies more... View contact profiles from Ambry Genetics, Whole Exome Sequencing Market to Reflect Significant Growth During 2020–2027 : BGI, Ambry Genetics, Eurofins Genomics, Etc, Scipher Medicine® and Ambry Genetics® Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market, First Prospective Study Shows +RNAinsight™ Identifies More Patients with Increased Risk for Hereditary Cancer Than DNA-Only Testing. Ambry News from GenomeWeb, your source for the latest Genetics & Genomics news, company information, and business listings. Hereditary Cancer Testing Market 2020 Size,Share with Top Key Players are Ambry Genetics (Konica Minota),Asper Biogene,Natera,Caris Life Sciences,BioReference Laboratories (GeneDx),LabSolutions,Progenity,Inc. The company is headquartered in Al... Read More. All rights reserved. Read the full press release at Ambry Genetics's main competitors are: Invitae, Novogene, MedGenome, Genetic Testing Laboratories. Who are Ambry Genetics’s main competitors? Find out how LUMITOS supports you with online marketing. Your changes will in fact be stored however can be lost at all times. Partnership provides infrastructure for rapid scaling and patient accessibility. Founded in 1999, Ambry Genetics provides clinical genetic diagnostics and genetics software solutions for medical facilities. See Ambry Genetics Corporation's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays. Ambry Genetics General Information Description. Subscribe to receive future Ambry updates! Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE. The initial certification is for Comparative Genomic Hybridization (aCGH) which is an application used by researchers to discover and detect genomic ... You will receive via e-mail the latest search results matching your search criteria. Contact Ambry Genetics today. This service is free of charge and can be cancelled at any time. Ambry Genetics has acquired the companies: Minolta, Depth Security, Serians S.A.S., Indicia Limited, The technologies that are used by Ambry Genetics are: IBM SPSS, MATLAB, Microsoft Project, Final Cut Pro, Ambry Genetics's CFO is Michael Martinson, See more information about Ambry Genetics, 1 Enterprise, Aliso Viejo, California, 92656, United States, New York, NY -- (SBWIRE) -- 10/09/2020 -- The report performs a systematic assessment of both the qualitative and quantitative factors of the Whole Exome Sequencing industry, alongside providing details on the market shares of the prominent companies operating in this industry and their financial standings. Please complete the form below and the appropriate Ambry representative will contact you. What companies has Ambry Genetics acquired? Find out more about the company LUMITOS and our team. The function "Store search" is only available to registered users. Ambry Genetics announced that they have completed certification to become an Agilent Certified Service Provider on the Agilent microarray platform. PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory. Ambry Genetics Corporation's top competitors are Roche, Illumina and 23andMe. © 1997-2020 LUMITOS AG, All rights reserved,, Your browser is not current. Press release - Market Growth Insight - Direct-to-consumer Genetic Testing Market Share and SWOT Analysis: Myriad Genetics Inc., 23andMe Inc., Invitae, Ambry Genetics - … Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting, JAMA Oncology Publishes Ambry’s Results Detailing Genes Associations with Hereditary Breast and Ovarian Cancer, Dr. John E. Niederhuber Appointed Chairman of Konica Minolta’s Scientific Advisory Board, Invicro and Ambry Genetics Appoint Dr. Kenneth Bloom as Chief Medical Officer of Advanced Pathology and Genomic Services, Ambry Genetics in Collaboration with Mayo Clinic and NorthShore University HealthSystem Announce Important Research Contributing to Breast Cancer Risk Prediction, Ambry Genetics Launches AmbryScoreTM to Assist Health Care Providers in Determining Lifetime Breast Cancer Risk, Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine, Ambry Appoints Linh H. Le as New Chief Operating Officer, Ambry Names Tom Schoenherr as Chief Commercial Officer, Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium. You are currently not logged in to .